| A consensus molecular classification of muscle-invasive bladder cancer A Kamoun, A de Reynies, Y Allory, G Sjödahl, AG Robertson, R Seiler, ... European urology 77 (4), 420-433, 2020 | 1016 | 2020 |
| EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype S Rebouissou, I Bernard-Pierrot, A de Reyniès, ML Lepage, C Krucker, ... Science translational medicine 6 (244), 244ra91-244ra91, 2014 | 382 | 2014 |
| Regional copy number–independent deregulation of transcription in cancer N Stransky, C Vallot, F Reyal, I Bernard-Pierrot, SGD De Medina, ... Nature genetics 38 (12), 1386-1396, 2006 | 270 | 2006 |
| Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes A Biton, I Bernard-Pierrot, Y Lou, C Krucker, E Chapeaublanc, ... Cell reports 9 (4), 1235-1245, 2014 | 215 | 2014 |
| Integrative modelling of the influence of MAPK network on cancer cell fate decision L Grieco, L Calzone, I Bernard-Pierrot, F Radvanyi, B Kahn-Perles, ... PLoS computational biology 9 (10), e1003286, 2013 | 205 | 2013 |
| Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b I Bernard-Pierrot, A Brams, C Dunois-Lardé, A Caillault, ... Carcinogenesis 27 (4), 740-747, 2006 | 172 | 2006 |
| Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer I Bernard-Pierrot, N Gruel, N Stransky, A Vincent-Salomon, F Reyal, ... Cancer research 68 (17), 7165-7175, 2008 | 108 | 2008 |
| Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy CS Groeneveld, J Fontugne, L Cabel, I Bernard-Pierrot, F Radvanyi, ... European Journal of Cancer 148, 181-189, 2021 | 105 | 2021 |
| Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis M Heroult, I Bernard-Pierrot, J Delbe, Y Hamma-Kourbali, P Katsoris, ... Oncogene 23 (9), 1745-1753, 2004 | 100 | 2004 |
| A siRNA screen identifies RAD21 , EIF3H , CHRAC1 and TANC2 as driver genes within the 8q23, 8q24 … SF Mahmood, N Gruel, E Chapeaublanc, A Lescure, T Jones, F Reyal, ... Carcinogenesis 35 (3), 670-682, 2014 | 90 | 2014 |
| Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes—a study of 130 invasive ductal breast carcinomas F Reyal, N Stransky, I Bernard-Pierrot, A Vincent-Salomon, Y de Rycke, ... Cancer research 65 (4), 1376-1383, 2005 | 87 | 2005 |
| Milk fat globule—epidermal growth factor—factor VIII (MFGE8)/lactadherin promotes bladder tumor development G Sugano, I Bernard-Pierrot, M Lae, C Battail, Y Allory, N Stransky, ... Oncogene 30 (6), 642-653, 2011 | 86 | 2011 |
| A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression C Vallot, N Stransky, I Bernard-Pierrot, A Hérault, J Zucman-Rossi, ... Journal of the National Cancer Institute 103 (1), 47-60, 2011 | 84 | 2011 |
| New blocking antibodies impede adhesion, migration and survival of ovarian cancer cells, highlighting MFGE8 as a potential therapeutic target of human ovarian carcinoma L Tibaldi, S Leyman, A Nicolas, S Notebaert, M Dewulf, TH Ngo, ... PLoS One 8 (8), e72708, 2013 | 82 | 2013 |
| A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression J Liu, D Ottaviani, M Sefta, C Desbrousses, E Chapeaublanc, R Aschero, ... Nature communications 12 (1), 5578, 2021 | 67 | 2021 |
| Recurrent activating mutations of PPARγ associated with luminal bladder tumors N Rochel, C Krucker, L Coutos-Thévenot, J Osz, R Zhang, E Guyon, ... Nature communications 10 (1), 253, 2019 | 60 | 2019 |
| An FGFR 3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers M Mahe, F Dufour, H Neyret‐Kahn, A Moreno‐Vega, C Beraud, M Shi, ... EMBO molecular medicine 10 (4), e8163, 2018 | 60 | 2018 |
| The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities I Bernard-Pierrot, J Delbé, D Caruelle, D Barritault, J Courty, PE Milhiet Journal of Biological Chemistry 276 (15), 12228-12234, 2001 | 58 | 2001 |
| Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer MJ Shi, XY Meng, J Fontugne, CL Chen, F Radvanyi, I Bernard-Pierrot Genome medicine 12, 1-20, 2020 | 52 | 2020 |
| APOBEC-mediated mutagenesis as a likely cause of FGFR3 S249C mutation over-representation in bladder cancer MJ Shi, XY Meng, P Lamy, AR Banday, J Yang, A Moreno-Vega, CL Chen, ... European urology 76 (1), 9-13, 2019 | 51 | 2019 |
